Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
Sign Up to like & getrecommendations! Published in 2022 at "Translational Psychiatry"
DOI: 10.1038/s41398-022-01884-3
Abstract: Clozapine is the most effective antipsychotic for patients with treatment-resistant schizophrenia. However, response is highly variable and possible genetic underpinnings of this variability remain unknown. Here, we performed polygenic risk score (PRS) analyses to estimate… read more here.
Keywords: genotype predicted; severity among; prs; symptom severity ... See more keywords